Trial Details

UNKNOWN
Basic Information
Clinical ID c2779
Identifier NCT02973542
Trial Title Ethosuximide to Treat IBS
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome
Interventions DRUG: Ethosuximide|OTHER: Placebo
Participant Information
Sponsor University Hospital, Clermont-Ferrand
City Clermont-Ferrand
Country/Region France
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2018-04-30
Primary Completion Date 2023-04
Completion Date 2023-05